Vidalista 60 contains 60 mg of tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor used primarily to treat erectile dysfunction (ED). While Vidalista 60 does not directly increase nitric oxide (NO) levels in the body, it plays a crucial role in enhancing the effects of nitric oxide during sexual stimulation.
When arousal occurs, nitric oxide is naturally released in the penile tissue. This release activates an enzyme called guanylate cyclase, which increases levels of cyclic guanosine monophosphate (cGMP). Elevated cGMP causes smooth muscle relaxation and vasodilation in the blood vessels of the penis, allowing increased blood flow and resulting in an erection.
Tadalafil in VIDALISTA 60 MG inhibits the PDE5 enzyme, which normally breaks down cGMP. By preventing cGMP degradation, tadalafil prolongs its effects, enhancing the nitric oxide–cGMP pathway and supporting sustained erections.
In summary, Vidalista 60 does not produce nitric oxide but amplifies its natural effects by maintaining higher cGMP levels. This process leads to improved blood flow and erectile function during sexual activity. However, this enhancement only occurs with sexual stimulation, as nitric oxide release is stimulus-dependent. Always consult a healthcare provider before using high-dose tadalafil.
Add your comment